HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parfums Givenchy v. Drug Emporium

This article was originally published in The Rose Sheet

Executive Summary

U.S. Court of Appeals for the Ninth Circuit affirms November 1992 district court ruling that permanently enjoined Drug Emporium from importing, selling, advertising, marketing or otherwise distributing the copyrighted box design for Givenchy's Amarige women's scent ("The Rose Sheet" Nov. 30, 1992, p. 1). The appeals court rejected Drug Emporium's argument that it is not liable under copyright law because it is protected by the "first sale" doctrine, which, according to the ruling, holds that "a sale of a 'lawfully made' copy terminates the copyright holder's authority to interfere with subsequent sales or distribution" of the copy. The appeals court ruled that the doctrine applies only to copies legally made and sold in the U.S.; therefore, Drug Emporium is not protected because Amarige and its packaging are manufactured in France. The decision does not technically bar Drug Emporium from selling the fragrance, but the drug chain would have to import the product without its box in order to do so. Drug Emporium plans to file a petition for reconsideration of the appeals decision and says it will take the case to the Supreme Court if necessary

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel